Researchers explain how use of a histone deacetylase inhibitor corrects the damage done by the genetic disorder Niewmann-Pick Type C and allowed once-diseased cells to function normally.
Researchers explain how use of a histone deacetylase inhibitor corrects the damage done by the genetic disorder Niewmann-Pick Type C and allowed once-diseased cells to function normally.